Castleview Partners »

Fs Global Cr Opportunitie Fda shares owned by Castleview Partners

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by Castleview Partners from 13F filings

Historical chart of Castleview Partners investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by Castleview Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by Castleview Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $455k 72k 6.35
2024-06-30 $39k 6.2k 6.37

More positions owned by Castleview Partners

Valued Advisers Tr Regan Fltg Rate (MBSF)
Apple (AAPL)
Amgen (AMGN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Amazon (AMZN)
Spdr Ser Tr Prtflo S&p500 Hi (SPYD)
Microsoft Corporation (MSFT)
Home Depot (HD)
Vaneck Etf Trust Clo Etf (CLOI)
Bristol Myers Squibb (BMY)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Vaneck Merk Gold Etf Gold Shs (OUNZ)
Proshares Tr Pshs Ultra Qqq (QLD)

View all positions for Castleview Partners

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Cambridge Investment Research Advisors
Nomura Holdings
Thomas J. Herzfeld Advisors
Wagner Wealth Management
Cetera Investment Advisers
LPL Financial
Envestnet Asset Management
H D Vest Advisory Services
Vista Finance
Rockefeller Capital Management
Advisor Group Holdings
Ellis Investment Partners
Private Advisor
Kestra Advisory Services

View all funds holding Fs Global Cr Opportunitie Fda